The aberrant methylation and downregulated expression of CST6 were also found in breast cancer patients, and the expression could reactivate after DNA demethylating agent treatment (Ai et al., 2006; Schagdarsurengin et al., 2007). The gene discussed is CST6; the disease is breast carcinoma.